Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial.

about

Body fat composition as predictive factor for treatment response in patients with newly diagnosed multiple myeloma - subgroup analysis of the prospective GMMG MM5 trial.

Item

http://www.wikidata.org/entity/Q42366623

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@en

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@nl

type

Item

label

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@en

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@nl

prefLabel

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@en

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@nl

P1476

Body fat composition as predic ...... he prospective GMMG MM5 trial.

@en

P2093

Diana Tichy

http://www.w3.org/2001/XMLSchema#string

Hans-Ulrich Kauczor

http://www.w3.org/2001/XMLSchema#string

Jens Hillengass

http://www.w3.org/2001/XMLSchema#string

Johanna Nattenmüller

http://www.w3.org/2001/XMLSchema#string

Jonathan P GroΔ

http://www.w3.org/2001/XMLSchema#string

Julia Krzykalla

http://www.w3.org/2001/XMLSchema#string

Maximilian Merz

http://www.w3.org/2001/XMLSchema#string

Stefan Delorme

http://www.w3.org/2001/XMLSchema#string

Stefan Hemmer

http://www.w3.org/2001/XMLSchema#string

Uta Bertsch

http://www.w3.org/2001/XMLSchema#string

P2860

Interpretation of cytogenetic results in multiple myeloma for clinical practice

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia

Pathophysiology of human visceral obesity: an update

Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Prevalence of childhood and adult obesity in the United States, 2011-2012

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study.

Determinants of bone microarchitecture and mechanical properties in obese men

Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study

P304

68460-68471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19536

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hartmut Goldschmidt

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28978130

http://www.w3.org/2001/XMLSchema#string

P932

5620270

http://www.w3.org/2001/XMLSchema#string